Patient P-01755
Synthetic patientNBL-101 · Day 120 · 55–64 · M · baseline S13Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
24%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S13
- Day 31 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 31.
Primary contributors, last 14 days
- Treatment adherence-7
- Toxicity-6
- GI instability+3
- Inflammatory activity+3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion29/100
improving · -10.3 vs previous 14 d
Toxicity
Blood21/100
worsening · +2.1 vs previous 14 d
Sleep quality
Wearable53/100
improving · +11.7 vs previous 14 d
Energy level
Daily log4.9/10
improving · +0.5 vs previous 14 d
Stress level
Daily log3.2/10
improving · -0.4 vs previous 14 d
Steps
Wearable3,319
improving · +571 vs previous 14 d
Adherence
Companion91.5 %
stable · +1.7 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 63 from the failing basin, 24 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
Main detractors to watch
- Poor metabolizerhidden · steering -12.7
- Enterobacteriaceae elevatedhidden · steering -7.4
- Poor-sleep weekperturbation · steering -3
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load-3.1no signal · 53%
- Dietary fat load-2.7no signal · 50%
- Insoluble fibre-1.4no signal · 25%
- Simple carbohydrates-1.1no signal · 20%
- Spicy / capsaicin+0.8no signal · 15%
- Alcohol+0.5no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↑45
- WearableResting HR 76 bpm
- Wearable3,319 steps/day
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.9 · butyrate capacity 71/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 62 ms
- Sleep
- 6.6 h
- Steps
- 4,109
- Resting HR
- 75 bpm
Daily log: GI score 29, nutritional resilience 63, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.